article thumbnail

NHS Patient Data Could Generate Billions For UK, But Is It OK To Go Down That Road?

Healthcare IT Today

In her recent piece, EY global health sciences […]. Still, given the financial benefits it could generate, I’m not surprised that people are still kicking around the idea, which is what makes the following article to be so interesting.

article thumbnail

Bonus Features – July 2, 2023 – Nuance and Epic integrate, 5 in 6 physicians say telemedicine improves continuity of care, news from HFMA, and more

Healthcare IT Today

The FCC is updating its Mapping Broadband Health in America platform to incorporate maternal health data , with the aim of identifying whether Internet connectivity is tied to disparities in maternal health outcomes and determining where interventions could have the greatest impact.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

mHealth Insights live from #HIMSS18

mHealth Insight

Fortunately I’ve managed to convince/beg the brilliant Dr Chris Bickford MD to step into my conference-floor-pounding-shoes and provide some opinions and live updates from the world’s biggest Health IT Conference and Exhibition being held in Las Vegas. Monday 5 March (14:00pm Lando 4401): THE JOURNEY TO MOBILITY.

mHealth 28
article thumbnail

HIStalk Interviews Stephen Brown, Director of Preventive Emergency Medicine, UI Health

HIStalk Interviews

Stephen Brown, MSW, LCSW is director of preventive emergency medicine at University of Illinois Hospital and Health Sciences System. I’m director of preventive emergency medicine at University of Illinois Hospital and Health Sciences System. Tell me about yourself and your job.

article thumbnail

Biomedical Knowledge Must Be Mobilized to Save Lives, Not Privatized in the “Last Mile”

Society for Participatory Medicine

Last week, Facebook’s unprecedented stock price collapse triggered by concerns over personal data privacy, as well as same-day commentary regarding GlaxoSmithKline’s investment in 23andMe to gain access to its customers’ genomic data, reignited a national dialogue vis-à-vis our rights to our data, especially our health data.